Healthcare -
Biotechnology - NASDAQ - US
$ 1.27
1.6 %
$ 145 M
Market Cap
-0.77
P/E
FATE - REVENUE
Revenue FATE - Fate Therapeutics, Inc.
63.5 M
LAST VALUE
6.66%
2 YEAR CAGR
68.05%
5 YEAR CAGR
51.91%
10 YEAR CAGR